迈得医疗工业设备股份有限公司2025年度业绩快报公告

Core Viewpoint - The company reported significant growth in its financial performance for the year 2025, with a notable increase in revenue and net profit, indicating a successful execution of its production plans and market strategies [3][4][5]. Financial Data and Indicators - The company achieved an operating income of 447.42 million yuan, a 62.79% increase compared to the previous year [3][5]. - Operating profit reached 59.70 million yuan, with a total profit of 61.22 million yuan [3]. - The net profit attributable to the parent company was 65.26 million yuan, while the net profit after deducting non-recurring gains and losses was 53.29 million yuan, marking a significant turnaround from losses in the previous year [3][5]. - Total assets at the end of the reporting period were 1.19 billion yuan, up 12.69% year-on-year [3]. - Shareholders' equity attributable to the parent company was 862.40 million yuan, an increase of 6.46% compared to the previous year [3]. - The net asset value per share was 5.19 yuan, reflecting a 6.57% increase year-on-year [3]. Business Performance and Financial Condition - The substantial growth in operating income was attributed to the orderly implementation of production plans, ensuring effective product delivery, and a dual focus on technological innovation and process iteration [4][5]. - The blood purification and medical device combination intelligent equipment sectors performed well, particularly due to strong demand for medical consumables in the terminal market, leading to optimistic market prospects for the medical device combination intelligent equipment [4][5]. - The company emphasized new product development and market expansion around the medical device combination intelligent equipment, resulting in significant revenue growth in this area [4][5].